Preventice Solutions has received a tender from the UK Biobank to provide the BodyGuardian® MINI remote cardiac monitor for a cardiovascular monitoring study involving up to 30,000 participants. The study is designed to capture data on asymptomatic heart rhythm disturbances (arrhythmia), including atrial fibrillation (AF), a common arrhythmia that can lead to stroke and cognitive decline (dementia).
Founded in 2004, headquartered in Minneapolis, Minnesota, Preventice Solutions is a leading developer of mobile health solutions and remote monitoring services that connect patients threatened by cardiac arrhythmias with their care team. Using insights to create revolutionary monitoring technologies, this tech-enabled, service-based approach can ultimately reduce the cost of care and improve health outcomes. The Preventice wearable portfolio includes the PatientCare Platform and BodyGuardian® family of monitors.
This British Heart Foundation (BHF) funded study is part of the UK Biobank Imaging Project, which is almost halfway to its goal of collecting detailed brain, heart and body scans of 100,000 of its volunteer participants. The BodyGuardian® MINI remote cardiac monitor will be used to obtain longer term heart rhythm data on a subset of participants 65 years of age and older. The project is anticipated to last around three years.
The BodyGuardian® MINI is the smallest, reusable Holter monitor available. It records important physiological data such as heart rate, ECG and related activity, allowing physicians to monitor vital signs outside the clinical setting. Unlike many other remote monitors, the MINI device offers a wearable patch that can be moved and reapplied to optimize comfort and wearability, without jeopardizing data collection or requiring the participant to return to the clinic. In addition, it is fully waterproof, allowing participants the freedom to go about their daily life without interrupting cardiac monitoring.
“Atrial fibrillation is a common condition that can go unnoticed until it causes a stroke or cognitive decline. We desperately need to know more about its causes and how it can be better treated.”… “UK Biobank provides us with an ideal opportunity to integrate a large amount of health, genetics and lifestyle information with heart rhythm data on a huge number of people. Importantly these individuals will have also undergone an MRI heart, body and brain scan. It is not often that all these opportunities for discovery come together – because of this, we believe this study will provide important answers about the management and risk associated with asymptomatic AF and other clinically silent arrhythmias.” – Study lead, Professor Barbara Casadei, BHF Professor of Cardiovascular Medicine, Cardiovascular Medicine Division of the Radcliffe Department of Medicine, University of Oxford
“The BodyGuardian® MINI was designed to enhance compliance through ease-of-use and comfort based on its small size and waterproof design allowing participants to go about their daily activities without interruption. We look forward to helping researchers pursue this important research and are pleased to partner with the UK Biobank, British Heart Foundation and the Radcliffe Department of Medicine at Oxford as they collaborate on important research efforts to further understand AF and its impact on stroke and cognitive decline.” – Jon Otterstatter, Chief Executive Officer, Preventice Solutions
Sources
